aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Babyscripts, founded in the United States, focuses on improving maternal health outcomes through innovative medical devices. Their core mission is to enhance clinical decision-making and care for pregnant women by providing personalized weight and blood pressure monitoring solutions. Babyscripts aims to ensure better access to care and risk detection for expectant mothers, offering a comprehensive program that supports healthcare providers in delivering timely and effective maternity care.
Notable affiliates include partnerships with healthcare organizations like Privia Health, which integrates Babyscripts' risk recognition and response tools into their maternity care workflows. The company has achieved significant milestones in enhancing maternal health outcomes and expanding access to care across the United States. Babyscripts' impact is evident in its ability to drive better clinical decisions and improve the overall quality of maternity care, making it a vital player in the healthcare technology sector.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Medical Devices
Technology
Telemedicine, HealthTech
Model Types
Hardware, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
United States
When was Babyscripts founded?
Babyscripts was founded in 2013.
Where is Babyscripts’s headquarters located?
Babyscripts’s headquarters is located in Washington, D.C., US.
When was Babyscripts’s last funding round?
Babyscripts’s most recent funding round was for $7.5M (USD) in November 2021.
How many employees does Babyscripts have?
Babyscripts has 68 employees as of Feb 4, 2024.
How much has Babyscripts raised to-date?
As of July 05, 2023, Babyscripts has raised a total of $39.8M (USD) since Nov 30, 2021.
Add Comparison
Total Raised to Date
$39.8M
USD
Last Update Nov 30, 2021
Last Deal Details
$7.5M
USD
Nov 30, 2021
Series B
Total Employees Over Time
68
As of Feb 2024
Babyscripts Address
1201 Connecticut Avenue NW
suite 200h
Washington, D.C.,
20036
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts